Raymond James Financial Services Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.64M | Sell |
|
|||||
|
2024
Q2 | $1.68M | Buy |
|
|||||
|
2024
Q1 | $1.61M | Sell |
|
|||||
|
2023
Q4 | $1.48M | Buy |
|
|||||
|
2023
Q3 | $258K | Sell |
|
|||||
|
2023
Q2 | $261K | Buy |
|
|||||
|
2023
Q1 | $214K | Sell |
|
|||||
|
2022
Q4 | $1.74M | Buy |
|
|||||
|
2022
Q3 | $219K | Sell |
|
|||||
|
2022
Q2 | $256K | Sell |
|
|||||
|
2022
Q1 | $277K | Buy |
|
|||||
|
2021
Q4 | $254K | Buy |
|
|||||
|
2021
Q3 | $239K | Buy |
|
|||||
|
2021
Q2 | $206K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $240K | Sell |
|
|||||
|
2017
Q4 | $350K | Buy |
|
|||||
|
2017
Q3 | $336K | Sell |
|
|||||
|
2017
Q2 | $2.87M | Buy |
|
|||||
|
2017
Q1 | $313K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $2.07M | Buy |
|